Phase 1
Programme Design and Qualification
1Develop Contamination Control Strategy
EU GMP Annex 1 2022 requires a formal CCS documenting the holistic approach to contamination prevention across facility design, personnel practices, cleaning and disinfection, environmental monitoring and CAPA. The CCS must be a living document updated when significant changes occur. FDA does not formally require a CCS document but expects equivalent contamination control principles to be demonstrated during inspection.
EU GMP Annex 1 2022 Section 2.2 · 21 CFR 211.42
↓
2Risk-based sampling location selection
Select monitoring locations based on documented risk assessment per ICH Q9(R1) 2023. Criteria: proximity to critical operations such as aseptic filling and open container handling, frequency of human intervention and manual manipulations, airflow pattern analysis in UDAF zones, historical contamination data from the facility, equipment design including dead legs and difficult-access areas. Sampling locations must include worst-case positions not representative positions.
EU GMP Annex 1 2022 Section 9 · ICH Q9(R1) 2023 · USP 1116
↓
3Set alert and action limits from historical data
Alert limits set at the 90th percentile of historical baseline data. Action limits set at the 95th percentile of historical baseline data. Both must be set below the regulatory specification limit for the grade. Limits derived from the specific facility's own historical data - not adopted from regulatory guideline values or generic industry references without facility-specific data supporting their use. Limits reviewed and updated periodically.
EU GMP Annex 1 2022 · USP 1116 · PDA TR 13 · Assyro May 2026
↓
4Qualify monitoring equipment and methods
Particle counters: calibrated per ISO 21501-4, probe placement qualified, isokinetic sampling velocity confirmed for UDAF zones. Microbial sampling: settle plates, active air samplers and surface contact plates qualified using appropriate growth promotion testing. Personnel monitoring: contact plates and glove fingertip sampling procedures validated. All methods documented in written sampling procedures with analyst training records.
ISO 14644-1:2015 · ISO 21501-4 · EU GMP Annex 1 2022 Section 9
Phase 2
Sampling and Testing
5Execute monitoring at defined frequency
Grade A: continuous particle monitoring during all critical operations per Annex 1 2022. Viable monitoring at each production session. Grade B: particle monitoring at defined frequency during operations. Settle plates for full duration of critical operations. Grade C and D: periodic monitoring at risk-based frequency. Personnel monitoring: at end of each session in critical areas. All monitoring conducted in operational as well as at-rest conditions for Grade A and B.
EU GMP Annex 1 2022 Section 9.2 to 9.5 · FDA Aseptic Guidance 2004
↓
6Incubate and read microbial samples
Incubation at two temperatures to recover both mesophiles and psychrophiles: 20 to 25 degrees Celsius for 5 to 7 days followed by 30 to 35 degrees for 3 to 5 days, or reverse order per PDA TR 13. Read plates at defined intervals. Record all results including zero counts. No selective discarding of results. Organisms recovered must be identified to genus and species level for Grade A and B using validated identification methods.
PDA TR 13 · EU GMP Annex 1 2022 · USP 1116
↓
Do results exceed alert limit or action limit?
Alert → Investigate
Action → Escalate
Within limits → Record and trend
↓ Within limits
7Record results and assess batch impact
All results recorded in the EM database with sampling location, date, operator, incubation conditions and organism identification for positive results. Assess whether results affect batch disposition for product manufactured during the monitoring period. Within-limit results contribute to ongoing trend dataset. Results retained as part of the batch record for the corresponding production period.
21 CFR 211.194 · ALCOA+ · EU GMP Annex 1 2022
Phase 3
Review and Trending
8Periodic trend analysis
Monthly trend review of all EM data. Compare current period results against historical baseline and established alert and action limits. Identify upward trends before limits are exceeded. A result at 78% of the action limit is a trend signal not a success. Three consecutive results in the 70% to 80% range in the same location require investigation of root cause before a limit exceedance occurs. Trending must be location-specific and organism-specific not just total count trending.
EU GMP Annex 1 2022 Section 9.33 · USP 1116 · PDA TR 13
↓
9Organism identification and disinfectant efficacy
Organisms recovered from Grade A and B must be identified to species level. Build a facility organism profile tracking which species are recovered most frequently and at which locations. Confirm that the disinfectant rotation programme is effective against the facility's own resident organisms - not just against panel organisms used in general disinfectant qualification studies. Resistant organism emergence must trigger disinfectant programme reassessment.
EU GMP Annex 1 2022 · GMPify Disinfectant Validation course
↓
10APQR and management review submission
EM trend data submitted to APQR and management review per ICH Q10 Section 3.2.1. Present: total exceedance count and rate by grade, location-specific trending, organism profile changes year on year, disinfectant efficacy assessment against facility organisms, alert and action limit review and any proposed limit updates. Management review conclusion must address systemic contamination patterns not just individual exceedance events.
ICH Q10 Sections 3.2.1 and 3.2.4 · 21 CFR 211.180(e)
Phase 4
Programme Maintenance
11Periodic limit review and update
Alert and action limits must be reviewed periodically and updated when the historical baseline data changes significantly. If facility improvements reduce the typical contamination burden the limits should be tightened to reflect the new baseline. Using limits derived from years-old data that no longer reflects current facility performance is a programme design deficiency. Limit review documented with the data supporting any changes and QA approval.
EU GMP Annex 1 2022 · USP 1116 · PDA TR 13
↓
12Equipment requalification schedule
Particle counters requalified annually per ISO 21501-4. Requalification triggered additionally by: equipment repair or modification, particle counter relocation, calibration failure, changes to monitored area design or HVAC. ISO 14644-2 defines requalification intervals for cleanroom classification testing. Qualification status of all monitoring equipment tracked in equipment management system with calibration due dates monitored.
ISO 14644-2 · ISO 21501-4 · EU GMP Annex 15
↓
13CCS review and update
The Contamination Control Strategy document must be reviewed and updated when significant changes occur to the facility, equipment, processes, personnel practices or product portfolio. Annex 1 2022 requires the CCS to be a living document. Annual CCS review documented even when no updates are required. CCS review is part of the management review agenda and feeds into the APQR for sterile products.
EU GMP Annex 1 2022 Section 2.2 · ICH Q10 Section 3.2.4
Alert and Action Limit Framework
Alert Limit - Investigate and Monitor
Set at the 90th percentile of facility historical baseline data. An alert limit exceedance indicates a potential deterioration in environmental control. It does not automatically require batch hold or production stoppage. Required response: investigation to determine whether the result represents a true environmental trend or an isolated event. Increased monitoring frequency. Documentation of investigation and conclusion.
EU GMP: alert limits set by facility historical data · USP 1116 Section 7
Action Limit - Escalate and Assess Batch Impact
Set at the 95th percentile of facility historical baseline data. An action limit exceedance requires immediate investigation, batch disposition assessment, root cause analysis, CAPA and written conclusion before resuming manufacturing. The German 2026 warning letter cited 47 action level exceedances over 27 months with a known design flaw never corrected. Action limits exceeded repeatedly with no corrective action are a systemic quality failure.
EU GMP: action limit exceedance triggers formal investigation · 21 CFR 211.113
Regulatory Specification Limits - Never Exceed
The limits published in EU GMP Annex 1 Table 1 and the FDA Aseptic Processing Guidance are regulatory specification limits - the maximum acceptable contamination level for each grade. Alert and action limits must both be set below specification limits. Exceeding a regulatory specification limit requires investigation, batch hold and regulatory assessment. A facility whose alert and action limits equal the specification limits has no early warning system.
EU GMP Annex 1 Table 1 · FDA Aseptic Guidance Appendix 1
Action Limit Exceedance - Required Response Steps
Step 1 - Immediate notification and batch hold assessment
Notify QA unit immediately. Assess whether product manufactured during the monitoring period should be placed on hold pending investigation. For Grade A exceedances during aseptic filling a hold is typically required until investigation excludes sterility impact.
Step 2 - Initial investigation - rule out sampling error
Assess whether the result could reflect a sampling technique error, incubation error or identification error before concluding a genuine environmental exceedance. If sampling error is confirmed with objective evidence document the invalidation. If not the exceedance must be investigated as genuine.
Step 3 - Root cause investigation
Investigate the source of contamination. Review personnel gowning records, cleaning and disinfection records, HVAC performance data, equipment maintenance records and recent facility activities. For repeated exceedances at the same location assess whether a structural contamination source such as a dead leg, damaged surface or deficient airflow pattern is responsible.
Step 4 - Organism identification and risk assessment
Identify the recovered organism to species level. Assess its significance based on its known pathogenicity, environmental persistence and its presence in the facility organism profile. A newly identified species or a significant increase in count of an existing species requires risk assessment per ICH Q9(R1) 2023.
Step 5 - CAPA with verified effectiveness
Implement CAPA addressing the root cause. Define effectiveness criterion before implementation. Monitor at increased frequency after CAPA implementation. Confirm the organism has been eliminated from the affected location before returning to standard monitoring frequency. Do not reduce monitoring frequency until three consecutive satisfactory results are obtained.
Key Trending Analyses Required
Location-specific trending
Track each monitoring location independently. A global site average that is within limits may mask an individual location trending toward its action limit. Location-specific trending is required to detect early contamination signals.
Organism profile trending
Track which organisms are recovered at each location over time. A change in the predominant organism type or the emergence of a new organism in Grade A indicates a new contamination source. The disinfectant programme must be assessed for efficacy against facility-specific organisms annually.
Personnel monitoring trending
Track gowning performance by individual and by gowning session. Persistent positive glove fingertip results for specific operators indicate a gowning technique problem requiring remediation. Personnel monitoring results must be linked to the batches produced by that personnel to enable full contamination source investigation.
Seasonal and maintenance correlation
Correlate EM results with HVAC maintenance records, filter changes, cleaning and disinfection rotation changes and seasonal temperature and humidity data. Seasonal patterns in contamination rates indicate environmental factors that the programme design should address proactively.